Pharma firms may have to return Rs 2,038-cr overcharged amount

DRL, Cipla Among Cos Found Involved In Overcharging By Drug Price Regulator

Read More
Publication Date: 
21/08/2009
Economic Times (New Delhi)
Tags:
Health, Health Care, Drugs, Drug Industry, India, Ranbaxy Pharmaceuticals